Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial

Journal of Crohn's & colitis

Volumn 11, Issue 5, 2017, Pages 527-533

  Turner, Dan ^a   Yerushalmi, Baruch ^a   Kori, Michal ^a   Broide, Efrat ^a   Mozer Glassberg, Yael ^a   Shaoul, Ron ^a   Kolho, Kaija Leena ^a   Shteyer, Eyal ^a   Shamaly, Hussein ^a   Ledder, Oren ^a   Cohen, Shlomi ^a   Peleg, Sarit ^a   On, Avi ^a   Levine, Arie ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

child; Drugs; ulcerative colitis

Indexed keywords

MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; CHILD; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REMISSION; ULCERATIVE COLITIS;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MESALAMINE; REMISSION INDUCTION;

EID: 85043365578     PISSN: None     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjw180     Document Type: Article

References (0)